• Chemical name: 17α-Methyl-2-hydroxymethylene-17β-hydroxy-[5α]-androstan-3-one
• Formula: C21H32O3
• Anabolic activity index: 320%
• Androgenic activity index: 45%

OXYMETOS 25 – PHARMACOM LABS

50 tabs x 25 mg (1 blister)

Oxymetholone, also known as Anapolon or Anadrol, is a potent synthetic steroid, a 17-alpha-alkylated modification of dihydrotestosterone. Originally developed for the treatment of osteoporosis and anemia, as well as to stimulate muscle gain in malnourished and debilitated patients, Oxymetholone was FDA-approved for human use. However, with the introduction of non-steroidal drugs effective in treating anemia and osteoporosis, its popularity waned, leading to the cessation of production by Syntex and other manufacturers in 1993.

Benefits:

• Initially designed for the treatment of osteoporosis, anemia, and muscle gain in malnourished patients.
• FDA-approved for human use, attesting to its efficacy in medical applications.
• Similar performance parameters to methandienone, resulting in active muscle bulking and a substantial increase in power performance.
• Provides a strong pumping effect due to its influence on hemoglobin levels and increased blood volume, complicating training but contributing to rapid muscle soreness.

Side Effects:

• Like methandienone, oxymetholone can cause water retention, leading to increased body weight and potential high blood pressure during cycles.
• Despite not aromatizing, oxymetholone exhibits pronounced estrogenic properties, necessitating the use of antiestrogens to manage estrogenic side effects.
• The estrogenic activity is suggested to be progestogenic, akin to nandrolones, but medical studies refute any progestogenic activity.

Dosage Instructions:

• Dosage recommendations should be obtained from a qualified healthcare professional or adhered to as per medical guidance.
• Due to its potent nature, careful monitoring of side effects and regular medical check-ups are advisable during the course of oxymetholone use.
• Anti-estrogens are recommended to combat estrogenic side effects, as aromatase inhibitors are not effective against oxymetholone’s estrogenic properties.